<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    Why did AUPH's Q4 2024 earnings fall short of forecasts?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/5/2025 02:11pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Aurinia Pharmaceuticals Inc. (AUPH) experienced a shortfall in its Q4 2024 earnings relative to forecasts due to several key factors:

1. **Revenue Disappointment**: The company's revenue for the quarter was $50.30 million, which missed the consensus estimate of $46.30 million. This discrepancy suggests that either the company's sales were lower than anticipated or cost management did not meet expectations.
2. **Strategic Review Impact**: Aurinia's previously announced strategic review did not yield positive results, as indicated by the company's disclosure. This strategic review process may have disrupted normal operations or led to inefficiencies, negatively impacting financial performance.

In summary, Aurinia's Q4 2024 earnings fell short due to a combination of revenue disappointment and the impact of the strategic review.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay){return {layout:"default",data:[{noData:c,currentQuestion:e,textDescription:I,comeFrom:"AInvestShareLink",events:[],answerSource:m}],fetch:{},error:n,state:{sharePreviewModule:{loadJgySuccess:g,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:1,agent_id:a,output_media_info:[],task_id:a,language:a,source:m,cache_builder:a,reply_action:"Answer",execute_mode:z,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"Why did AUPH's Q4 2024 earnings fall short of forecasts?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"Why did AUPH's Q4 2024 earnings fall short of forecasts?\",\"user_id\":\"dp22744417\",\"user_name\":\"\",\"trace_id\":\"1327736a-eb28-4efe-9d06-668366eb7d79\",\"session_id\":\"1327736a-eb28-4efe-9d06-668366eb7d79\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:J,raw_data:{number:t,title:K,summary:L,full_summary:a,url:M,image_url:a,video_url:a,publish_time:N,search_extra_info:{search_burial_info:{id:O,uid:A,ab:{scene_id:u,layer_exp:[{layer_id:v,exp_id:w}]}}},simhash:"bed125232488b8a",msg_id:A}},{info_type:J,raw_data:{number:P,title:Q,summary:R,full_summary:a,url:S,image_url:a,video_url:a,publish_time:T,search_extra_info:{search_burial_info:{id:U,uid:B,ab:{scene_id:u,layer_exp:[{layer_id:v,exp_id:w}]}}},simhash:"600b1e637df66e9a",msg_id:B}}],answer_chain_name:V,agent_mode:W,native_answer:a,come_from:a,text_answer:I,trace_id:f,cost:13594,event_names:a,question:e,fallback_type:X,input_type:Y,fall_back_reason:{fall_back_type:X,risk_detail:{matched_words:[]}},session_id:f,first_return_cost:3596,cache_type:a,question_id:f,transfer_question:e,signal_type:"ON_COMPLETE",start_time:Z,remote_svc:m,slots:[],answer_type:z,user_id:x,skill_name:C},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:f,session_id:f,user_id:x,question:e,source:m,raw_question:e,version:"3.4.1",action_name:C,nlu:{entity:[{type:_,value:"AUPH.O",market:$}]},deep_research:c,deep_thinking:c,agent_mode:W},extra:{}},{answer_path:h,section:{id:i,info_texts:["Thinking"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: AUPH Net Income, Net Income Surprise"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:D},logs:[],extra:{action:"Querying Stock",action_input:"AUPH Net Income, Net Income Surprise",thought:E}},{answer_path:h,section:{id:i,info_texts:["Searching Web: Aurinia Pharmaceuticals analyst opinions"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:D},logs:[],extra:{action:aa,action_input:"Aurinia Pharmaceuticals analyst opinions",thought:E}},{answer_path:h,section:{id:i,info_texts:["Searching Web: why Aurinia Pharmaceuticals Net Income bad"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:D},logs:[],extra:{action:aa,action_input:"why Aurinia Pharmaceuticals Net Income bad",thought:E}},{answer_path:d,section:{id:ab,info_texts:[],show_type:F,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:ab,info_texts:[],show_type:F,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Generating Answer"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:o,info_texts:[],show_type:k,voice_txt:"A",text_answer:ac,rich_text:ac,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"AUPH",market_id:$,name:ad,domain:_},pos:g,section_id:o,txt:ad,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:o,info_texts:[],show_type:k,voice_txt:".",text_answer:ae,rich_text:ae,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:af,info_texts:[],show_type:k,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{url:M,image_url:a,video_url:a,title:K,summary:L,index:t,publish_time:N,search_id:O,search_uid:A,search_ab:{scene_id:u,layer_exp:[{layer_id:v,exp_id:w}]},jump_type:ag}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:o,info_texts:[],show_type:k,voice_txt:". This",text_answer:ah,rich_text:ah,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:af,info_texts:[],show_type:k,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{url:S,image_url:a,video_url:a,title:Q,summary:R,index:P,publish_time:T,search_id:U,search_uid:B,search_ab:{scene_id:u,layer_exp:[{layer_id:v,exp_id:w}]},jump_type:ag}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:o,info_texts:[],show_type:k,voice_txt:".\n\nIn",text_answer:ai,rich_text:ai,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:h,section:{id:i,info_texts:["Completed"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:p,query_text:p,trace_info:{item_id:"e4e9f44d1746cd0957b3055f8e590e9b",item_type:l,item_name:p,rec_info:aj}},{display_text:q,query_text:q,trace_info:{item_id:"a717a92837dee42cccac66ec0dec3654",item_type:l,item_name:q,rec_info:ak}},{display_text:r,query_text:r,trace_info:{item_id:"224bd07b97890d45c9d787f0d632b5c8",item_type:l,item_name:r,rec_info:al}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:g,type:"1",display2:c,url:a}},request_config:[{source_type:t,related_name:am}],puuid:G,tag:a,category:"custom",uuid:an}],global:{urp_static_data:[{name:am,value:{status_code:g,columns:[{type:s,index_name:ao,key:ao},{type:s,index_name:ap,key:ap},{type:s,index_name:aq,key:aq},{type:s,index_name:ar,key:ar},{type:s,index_name:as,key:as}],datas:[{send_text:p,item_type:l,rec_info:aj,display_text:p,rec_reason:a},{send_text:q,item_type:l,rec_info:ak,display_text:q,rec_reason:a},{send_text:r,item_type:l,rec_info:al,display_text:r,rec_reason:a}],dataSize:t,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:at,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:y,"min-height":"100%",position:au,height:y},isMaterial:c,id:at,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:g,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:H,componentUuid:an,script:[{name:av,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:H,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:H},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:y,position:au,height:y},isMaterial:b,_id:19,id:av,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:aw,voice_txt:a,tracking_info:{},uuid:G},order:{is_auto:c,render_for:aw,chart_type:"command",puuid:G}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:F,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:C,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:z,answer_chain_name:V},is_deep_research:c,deep_thinking:c,create_time:1743833474355},is_last:b}],questionItem:{data:{qStr:e,encodeFlag:c,imageData:n,docsData:[],quoteData:n},tplType:"question"},events:ax,agentId:a,param:{entity_info:{},add_info:{ori_question:e},event_list:ax,client_ip:a,question:e,user_id:x,user_name:a,trace_id:f,session_id:f,source:m,input_type:Y}}],userId:x,userName:a,startTime:Z,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:n,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:g,traceTableData:n,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fauphs-q4-2024-earnings-fall-short-forecasts-ac1851\u002F",config:{_app:{basePath:ay,assetsPath:ay,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer","Why did AUPH's Q4 2024 earnings fall short of forecasts?","1327736a-eb28-4efe-9d06-668366eb7d79",0,"progress\u002Fsearching_for",1000,"searching_for","rich_text","llm_generated","ths_ainvest_lite_web",null,2001,"📈 What guidance did AUPH provide for future earnings?","⚠️ What are the potential risks and challenges facing AUPH?","🔍 Are there any catalysts that could turn AUPH's stock around?","STR",3,"oeqxkhszf","oeqxkhszf_layer","base","dp22744417","auto","agent","6f4649e6dfdabb43","76c4b182fc8ad220","explain news events","thinking","The user wants to analyze why AUPH's 2024 Q4 earnings fell short of market expectations. I should focus on earnings, earnings surprise, analyst opinions, and factors contributing to the earnings shortfall. I will use FinQuery for earnings, earnings surprise, and analyst opinions; use Search for factors contributing to the earnings shortfall.","signal","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Aurinia Pharmaceuticals Inc. (AUPH) experienced a shortfall in its Q4 2024 earnings relative to forecasts due to several key factors:\n\n1. **Revenue Disappointment**: The company's revenue for the quarter was $50.30 million, which missed the consensus estimate of $46.30 million. This discrepancy suggests that either the company's sales were lower than anticipated or cost management did not meet expectations.\n2. **Strategic Review Impact**: Aurinia's previously announced strategic review did not yield positive results, as indicated by the company's disclosure. This strategic review process may have disrupted normal operations or led to inefficiencies, negatively impacting financial performance.\n\nIn summary, Aurinia's Q4 2024 earnings fell short due to a combination of revenue disappointment and the impact of the strategic review.","search","Goldman Sachs Group Inc. Acquires 576,120 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)","Aurinia Pharmaceuticals had a negative return on equity of 15.06% and a negative net margin of 32.69%. The firm had revenue of $50.30 million for the quarter, compared to the consensus estimate of $46.30 million. Analysts predict that Aurinia Pharmaceuticals Inc. will post 0.15 EPS for the current y...","https:\u002F\u002Fwww.americanbankingnews.com\u002F2024\u002F06\u002F27\u002Fgoldman-sachs-group-inc-acquires-576120-shares-of-aurinia-pharmaceuticals-inc-nasdaqauph.html","2024-06-26","6f4649e6dfdabb43_1",8,"Aurinia drops after Q4 miss; strategic review fails","CharlieAJA\u002FiStock via Getty Images Aurinia Pharmaceuticals (NASDAQ:AUPH) lost ~25% premarket Thursday after the Canadian biotech fell short of Street forecasts with its Q4 2023 financials and said its previously announced strategic review didn’t generate positive results. While the strategic review ...","https:\u002F\u002Fseekingalpha.com\u002Fnews\u002F4067493-aurinia-stock-drops-q4-miss-failed-strategic-review","2024-02-15","76c4b182fc8ad220_0","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1743833460761,"stock","185","Searching Web",999,"Aurinia Pharmaceuticals Inc. (AUPH) experienced a shortfall in its Q4 2024 earnings relative to forecasts due to several key factors:\n\n1","Aurinia",". **Revenue Disappointment**: The company's revenue for the quarter was $50.30 million, which missed the consensus estimate of $46.30 million[^3]",2000,"normal",". This discrepancy suggests that either the company's sales were lower than anticipated or cost management did not meet expectations.\n2. **Strategic Review Impact**: Aurinia's previously announced strategic review did not yield positive results, as indicated by the company's disclosure. This strategic review process may have disrupted normal operations or led to inefficiencies, negatively impacting financial performance[^8]",".\n\nIn summary, Aurinia's Q4 2024 earnings fell short due to a combination of revenue disappointment and the impact of the strategic review.","2+707_496_21_554+0+0+1327736a-eb28-4efe-9d06-668366eb7d79+e4e9f44d1746cd0957b3055f8e590e9b+llm_generated+aimeTagAnalysis+0+0.08073587715625763+1","2+707_496_21_554+0+0+1327736a-eb28-4efe-9d06-668366eb7d79+a717a92837dee42cccac66ec0dec3654+llm_generated+aimeTagAnalysis+0+0.059429366141557693+2","2+707_496_21_554+0+0+1327736a-eb28-4efe-9d06-668366eb7d79+224bd07b97890d45c9d787f0d632b5c8+llm_generated+aimeTagAnalysis+0+0.03698384016752243+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>